menopause. Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
Conditions
Interventions
Control group: 3 milligram tablets of placebo of melatonin every night between 6 and 9 P.M. for 3 months
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having general health according to the Goldberg's questionnaire; i.e., getting 40. Exclusion criteria: Suffering from liver, kidney, and digestive diseases, inability to continue taking medication for any reason, unwillingness to cooperate after the beginning of the study, and showing allergic reactions to medication.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laboratory and clinical signs of menopause. Timepoint: Before intervention,1 ,2 and 3 month after intervention. Method of measurement: –In this study, climactric symptoms were measured through Greene questionnaire and female sexual function index questionnaire was used in order to assess the subjects' sexual function. In addition, FSH and EST were measured based on the international units. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of clinical symptoms. Timepoint: Before intervention,1,2 and 3 month after intervention. Method of measurement: Completed questionnaires before and during 3 months after clinical symptoms and laboratory measurements before and after intervention. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadijeh Abdali
Fatemeh (PBUH) College of Nursing and Midwifery, Shiraz
Outcome results
None listed